-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Only Two Days Left To Cash In On Touchstone International Medical Science's (SHSE:688013) Dividend
Only Two Days Left To Cash In On Touchstone International Medical Science's (SHSE:688013) Dividend
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Touchstone International Medical Science Co., Ltd. (SHSE:688013) is about to trade ex-dividend in the next 2 days. The ex-dividend date is one business day before a company's record date, which is the date on which the company determines which shareholders are entitled to receive a dividend. The ex-dividend date is an important date to be aware of as any purchase of the stock made on or after this date might mean a late settlement that doesn't show on the record date. Therefore, if you purchase Touchstone International Medical Science's shares on or after the 23rd of June, you won't be eligible to receive the dividend, when it is paid on the 23rd of June.
The company's next dividend payment will be CN¥0.20 per share, and in the last 12 months, the company paid a total of CN¥0.20 per share. Calculating the last year's worth of payments shows that Touchstone International Medical Science has a trailing yield of 1.0% on the current share price of CN¥19.89. Dividends are a major contributor to investment returns for long term holders, but only if the dividend continues to be paid. As a result, readers should always check whether Touchstone International Medical Science has been able to grow its dividends, or if the dividend might be cut.
View our latest analysis for Touchstone International Medical Science
Dividends are typically paid out of company income, so if a company pays out more than it earned, its dividend is usually at a higher risk of being cut. Touchstone International Medical Science paid out a comfortable 45% of its profit last year. That said, even highly profitable companies sometimes might not generate enough cash to pay the dividend, which is why we should always check if the dividend is covered by cash flow. Fortunately, it paid out only 34% of its free cash flow in the past year.
It's encouraging to see that the dividend is covered by both profit and cash flow. This generally suggests the dividend is sustainable, as long as earnings don't drop precipitously.
Click here to see how much of its profit Touchstone International Medical Science paid out over the last 12 months.
SHSE:688013 Historic Dividend June 20th 2022Have Earnings And Dividends Been Growing?
When earnings decline, dividend companies become much harder to analyse and own safely. Investors love dividends, so if earnings fall and the dividend is reduced, expect a stock to be sold off heavily at the same time. Touchstone International Medical Science's earnings per share plummeted 25% over the past year,which is rarely good news for the dividend.
Given that Touchstone International Medical Science has only been paying a dividend for a year, there's not much of a past history to draw insight from.
Final Takeaway
Is Touchstone International Medical Science an attractive dividend stock, or better left on the shelf? Touchstone International Medical Science has comfortably low cash and profit payout ratios, which may mean the dividend is sustainable even in the face of a sharp decline in earnings per share. Still, we consider declining earnings to be a warning sign. In summary, while it has some positive characteristics, we're not inclined to race out and buy Touchstone International Medical Science today.
So while Touchstone International Medical Science looks good from a dividend perspective, it's always worthwhile being up to date with the risks involved in this stock. Every company has risks, and we've spotted 2 warning signs for Touchstone International Medical Science you should know about.
Generally, we wouldn't recommend just buying the first dividend stock you see. Here's a curated list of interesting stocks that are strong dividend payers.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Touchstone International Medical Science Co., Ltd. (SHSE:688013) is about to trade ex-dividend in the next 2 days. The ex-dividend date is one business day before a company's record date, which is the date on which the company determines which shareholders are entitled to receive a dividend. The ex-dividend date is an important date to be aware of as any purchase of the stock made on or after this date might mean a late settlement that doesn't show on the record date. Therefore, if you purchase Touchstone International Medical Science's shares on or after the 23rd of June, you won't be eligible to receive the dividend, when it is paid on the 23rd of June.
老讀者會知道我們喜歡Simply Wall St.的紅利,這就是為什麼看到試金石國際醫學科學有限公司。(上海證券交易所股票代碼:688013)將在未來兩天內進行除股息交易。除息日期是公司記錄日期的前一個工作日,也就是公司決定哪些股東有權獲得股息的日期。除息日期是一個需要注意的重要日期,因為在這個日期或之後購買股票可能意味着延遲結算,而不會顯示在記錄日期上。因此,如果您在6月23日或之後購買Touchstone International Medical Science的股票,當6月23日支付股息時,您將沒有資格獲得股息。
The company's next dividend payment will be CN¥0.20 per share, and in the last 12 months, the company paid a total of CN¥0.20 per share. Calculating the last year's worth of payments shows that Touchstone International Medical Science has a trailing yield of 1.0% on the current share price of CN¥19.89. Dividends are a major contributor to investment returns for long term holders, but only if the dividend continues to be paid. As a result, readers should always check whether Touchstone International Medical Science has been able to grow its dividends, or if the dividend might be cut.
該公司下一次派息將為每股0.2元人民幣,最近12個月,公司共支付每股0.2元人民幣。計算上一年的支付價值顯示,試金石國際醫療科學公司目前的股價為19.89元,往績收益率為1.0%。股息是長期持有者投資回報的主要貢獻者,但前提是繼續支付股息。因此,讀者應該經常查看Touchstone International Medical Science是否能夠增加股息,或者股息是否可能被削減。
View our latest analysis for Touchstone International Medical Science
查看我們對試金石國際醫學科學的最新分析
Dividends are typically paid out of company income, so if a company pays out more than it earned, its dividend is usually at a higher risk of being cut. Touchstone International Medical Science paid out a comfortable 45% of its profit last year. That said, even highly profitable companies sometimes might not generate enough cash to pay the dividend, which is why we should always check if the dividend is covered by cash flow. Fortunately, it paid out only 34% of its free cash flow in the past year.
股息通常從公司收入中支付,因此,如果一家公司支付的股息超過了它的收入,它的股息通常被削減的風險更高。Touchstone國際醫學科學公司去年支付了相當於其利潤的45%。這就是説,即使是高利潤的公司有時也可能無法產生足夠的現金來支付股息,這就是為什麼我們應該總是檢查股息是否由現金流覆蓋。幸運的是,它在過去一年中只支付了自由現金流的34%。
It's encouraging to see that the dividend is covered by both profit and cash flow. This generally suggests the dividend is sustainable, as long as earnings don't drop precipitously.
看到利潤和現金流都涵蓋了股息,這是令人鼓舞的。這通常表明,只要收益不會急劇下降,股息是可持續的。
Click here to see how much of its profit Touchstone International Medical Science paid out over the last 12 months.
點擊這裏查看Touchstone International Medical Science在過去12個月中支付了多少利潤。
Have Earnings And Dividends Been Growing?
盈利和股息一直在增長嗎?
When earnings decline, dividend companies become much harder to analyse and own safely. Investors love dividends, so if earnings fall and the dividend is reduced, expect a stock to be sold off heavily at the same time. Touchstone International Medical Science's earnings per share plummeted 25% over the past year,which is rarely good news for the dividend.
當收益下降時,股利公司就更難分析和安全持有了。投資者喜歡分紅,所以如果收益下降,股息減少,預計一隻股票將同時被大量拋售。Touchstone International Medical Science的每股收益在過去一年裏暴跌了25%,這對股息來説很少是好消息。
Given that Touchstone International Medical Science has only been paying a dividend for a year, there's not much of a past history to draw insight from.
鑑於試金石國際醫學科學公司只支付了一年的紅利,沒有多少過去的歷史可以借鑑。
Final Takeaway
最終外賣
Is Touchstone International Medical Science an attractive dividend stock, or better left on the shelf? Touchstone International Medical Science has comfortably low cash and profit payout ratios, which may mean the dividend is sustainable even in the face of a sharp decline in earnings per share. Still, we consider declining earnings to be a warning sign. In summary, while it has some positive characteristics, we're not inclined to race out and buy Touchstone International Medical Science today.
試金石國際醫學科學公司是一隻有吸引力的股息股票,還是更好地被擱置?Touchstone International Medical Science的現金和利潤支付率非常低,這可能意味着即使在每股收益大幅下降的情況下,股息也是可持續的。儘管如此,我們認為盈利下降是一個警告信號。總而言之,雖然它有一些積極的特點,但我們今天並不傾向於競相收購Touchstone International Medical Science。
So while Touchstone International Medical Science looks good from a dividend perspective, it's always worthwhile being up to date with the risks involved in this stock. Every company has risks, and we've spotted 2 warning signs for Touchstone International Medical Science you should know about.
因此,儘管Touchstone International Medical Science從股息角度看起來不錯,但瞭解這隻股票所涉及的風險總是值得的。每家公司都有風險,我們已經發現試金石國際醫學科學的2個警告標誌你應該知道。
Generally, we wouldn't recommend just buying the first dividend stock you see. Here's a curated list of interesting stocks that are strong dividend payers.
一般來説,我們不會建議只購買你看到的第一批股息股票。這是這是一份精心挑選的股息支付強勁的有趣股票的名單。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧